Implant Intraocular Lens Comprehensive Study by Type (Accommodative Intraocular Lens, Monofocal Intraocular Lens, Multifocal Intraocular Lens, Toric Intraocular Lens), End-users (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, Eye Research Institutes) Players and Region - Global Market Outlook to 2030

Implant Intraocular Lens Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.3%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Intraocular lens (IOL) implant is an acrylic substitute for your eye’s herbal lens and takes over the image-focusing characteristic in your eye. The IOL, simply like the herbal lens, focuses mild interior the eye. IOLs are capable to right a wider vary of imaginative and prescient issues than any different imaginative and prescient correction surgery. They can be used to right myopia, hyperopia, astigmatism, and presbyopia (the issue focusing up shut that begins round age 40). An IOL is about 1/3 the measurement of a dime. It is round in the core and has fingers referred to as “haptics” on both facet which keep it in place. The IOL replaces the eyes herbal lens. The lens is first removed with the aid of a manner referred to as phacoemulsification. A small incision is made in the facet of the cornea. Then, the lens is damaged into small portions and rinsed from the eye. The IOL is folded and inserted via the small incision so that it rests in the identical clear tablet the place the herbal lens as soon as did.

Highlights from Implant Intraocular Lens Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR20.3%


The key Players profiled in the report are Alcon, Inc. (Switzerland), Johnson and Johnson Vision Care, Inc. (United States), Bausch & Lomb Incorporated (Canada), Carl Zeiss Meditec AG (ZEISS International) (Germany), Rayner (United Kingdom), EyeKon Medical, Inc. (United States), Lenstec, Inc. (United States) and HumanOptics AG (Germany). Additionally, other players that are part of this comprehensive study are STAAR Surgical Company (United States) and HOYA CORPORATION (Japan).

Geographic Breakdown and Segment Analysis
The Global Implant Intraocular Lens market presents a comprehensive analysis of the Implant Intraocular Lens market by product type (Accommodative Intraocular Lens, Monofocal Intraocular Lens, Multifocal Intraocular Lens and Toric Intraocular Lens), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Implant Intraocular Lens industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Implant Intraocular Lens market

Analyst at AMA have segmented the market study of Global Implant Intraocular Lens market by Type, Application and Region.

Market Growth Drivers:
Growing Incidence of Visual Impairments, Increasing Cases of Cataract in the Diabetic Population and Rising Adoption of Advanced Premium IOLs

Challenges:
Side Effects occur Lose Vision and Increased Intraocular Pressure

Restraints:
High Cost of IOLs and Lack of Reimbursement Policies

Opportunities:
Growth in Healthcare Expenditure

Market Developments Activities:
In June 2021, Bausch & Lomb partnered with Prevent Blindness, a non-profit organization, to increase focus and train the public concerning the symptoms, causes, and therapy preferences for cataracts at some stage in the cataract cognizance month.
In November 2021, Alcon, Inc. announced its intention to gather Ivantis, a enterprise that develops and manufactures minimally-invasive surgical procedure gadgets for glaucoma. The meant acquisition affirms Alcon’s dedication to similarly give a boost to its industry-leading portfolio throughout refractive, retina, cataract, and glaucoma. and In July 2021, Carl Zeiss Meditec AG introduced the launch of its new ZEISS clinical ecosystem. The agency ambitions to introduce a completely built-in environment, which is technologically advanced, whereby a mixture of devices, applications, facts management, and offerings propel regular enchancment of affected person outcomes.



The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies.

Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Accommodative Intraocular Lens
  • Monofocal Intraocular Lens
  • Multifocal Intraocular Lens
  • Toric Intraocular Lens
By End-users
  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgery Centers
  • Eye Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Incidence of Visual Impairments
      • 3.2.2. Increasing Cases of Cataract in the Diabetic Population
      • 3.2.3. Rising Adoption of Advanced Premium IOLs
    • 3.3. Market Challenges
      • 3.3.1. Side Effects occur Lose Vision
      • 3.3.2. Increased Intraocular Pressure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Implant Intraocular Lens, by Type, End-users and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Implant Intraocular Lens (Value)
      • 5.2.1. Global Implant Intraocular Lens by: Type (Value)
        • 5.2.1.1. Accommodative Intraocular Lens
        • 5.2.1.2. Monofocal Intraocular Lens
        • 5.2.1.3. Multifocal Intraocular Lens
        • 5.2.1.4. Toric Intraocular Lens
      • 5.2.2. Global Implant Intraocular Lens by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ophthalmic Clinics
        • 5.2.2.3. Ambulatory Surgery Centers
        • 5.2.2.4. Eye Research Institutes
      • 5.2.3. Global Implant Intraocular Lens Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Implant Intraocular Lens: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alcon, Inc. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson and Johnson Vision Care, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bausch & Lomb Incorporated (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Carl Zeiss Meditec AG (ZEISS International) (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Rayner (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. EyeKon Medical, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lenstec, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. HumanOptics AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Implant Intraocular Lens Sale, by Type, End-users and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Implant Intraocular Lens (Value)
      • 7.2.1. Global Implant Intraocular Lens by: Type (Value)
        • 7.2.1.1. Accommodative Intraocular Lens
        • 7.2.1.2. Monofocal Intraocular Lens
        • 7.2.1.3. Multifocal Intraocular Lens
        • 7.2.1.4. Toric Intraocular Lens
      • 7.2.2. Global Implant Intraocular Lens by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ophthalmic Clinics
        • 7.2.2.3. Ambulatory Surgery Centers
        • 7.2.2.4. Eye Research Institutes
      • 7.2.3. Global Implant Intraocular Lens Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Implant Intraocular Lens: by Type(USD Million)
  • Table 2. Implant Intraocular Lens Accommodative Intraocular Lens , by Region USD Million (2018-2023)
  • Table 3. Implant Intraocular Lens Monofocal Intraocular Lens , by Region USD Million (2018-2023)
  • Table 4. Implant Intraocular Lens Multifocal Intraocular Lens , by Region USD Million (2018-2023)
  • Table 5. Implant Intraocular Lens Toric Intraocular Lens , by Region USD Million (2018-2023)
  • Table 6. Implant Intraocular Lens: by End-users(USD Million)
  • Table 7. Implant Intraocular Lens Hospitals , by Region USD Million (2018-2023)
  • Table 8. Implant Intraocular Lens Ophthalmic Clinics , by Region USD Million (2018-2023)
  • Table 9. Implant Intraocular Lens Ambulatory Surgery Centers , by Region USD Million (2018-2023)
  • Table 10. Implant Intraocular Lens Eye Research Institutes , by Region USD Million (2018-2023)
  • Table 11. South America Implant Intraocular Lens, by Country USD Million (2018-2023)
  • Table 12. South America Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 13. South America Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 14. Brazil Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 15. Brazil Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 16. Argentina Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 17. Argentina Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 18. Rest of South America Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 19. Rest of South America Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 20. Asia Pacific Implant Intraocular Lens, by Country USD Million (2018-2023)
  • Table 21. Asia Pacific Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 22. Asia Pacific Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 23. China Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 24. China Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 25. Japan Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 26. Japan Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 27. India Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 28. India Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 29. South Korea Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 30. South Korea Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 31. Taiwan Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 32. Taiwan Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 33. Australia Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 34. Australia Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 37. Europe Implant Intraocular Lens, by Country USD Million (2018-2023)
  • Table 38. Europe Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 39. Europe Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 40. Germany Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 41. Germany Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 42. France Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 43. France Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 44. Italy Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 45. Italy Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 46. United Kingdom Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 47. United Kingdom Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 48. Netherlands Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 49. Netherlands Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 50. Rest of Europe Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 51. Rest of Europe Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 52. MEA Implant Intraocular Lens, by Country USD Million (2018-2023)
  • Table 53. MEA Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 54. MEA Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 55. Middle East Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 56. Middle East Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 57. Africa Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 58. Africa Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 59. North America Implant Intraocular Lens, by Country USD Million (2018-2023)
  • Table 60. North America Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 61. North America Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 62. United States Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 63. United States Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 64. Canada Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 65. Canada Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 66. Mexico Implant Intraocular Lens, by Type USD Million (2018-2023)
  • Table 67. Mexico Implant Intraocular Lens, by End-users USD Million (2018-2023)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Implant Intraocular Lens: by Type(USD Million)
  • Table 77. Implant Intraocular Lens Accommodative Intraocular Lens , by Region USD Million (2025-2030)
  • Table 78. Implant Intraocular Lens Monofocal Intraocular Lens , by Region USD Million (2025-2030)
  • Table 79. Implant Intraocular Lens Multifocal Intraocular Lens , by Region USD Million (2025-2030)
  • Table 80. Implant Intraocular Lens Toric Intraocular Lens , by Region USD Million (2025-2030)
  • Table 81. Implant Intraocular Lens: by End-users(USD Million)
  • Table 82. Implant Intraocular Lens Hospitals , by Region USD Million (2025-2030)
  • Table 83. Implant Intraocular Lens Ophthalmic Clinics , by Region USD Million (2025-2030)
  • Table 84. Implant Intraocular Lens Ambulatory Surgery Centers , by Region USD Million (2025-2030)
  • Table 85. Implant Intraocular Lens Eye Research Institutes , by Region USD Million (2025-2030)
  • Table 86. South America Implant Intraocular Lens, by Country USD Million (2025-2030)
  • Table 87. South America Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 88. South America Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 89. Brazil Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 90. Brazil Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 91. Argentina Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 92. Argentina Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 93. Rest of South America Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 94. Rest of South America Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 95. Asia Pacific Implant Intraocular Lens, by Country USD Million (2025-2030)
  • Table 96. Asia Pacific Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 97. Asia Pacific Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 98. China Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 99. China Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 100. Japan Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 101. Japan Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 102. India Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 103. India Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 104. South Korea Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 105. South Korea Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 106. Taiwan Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 107. Taiwan Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 108. Australia Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 109. Australia Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 110. Rest of Asia-Pacific Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 111. Rest of Asia-Pacific Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 112. Europe Implant Intraocular Lens, by Country USD Million (2025-2030)
  • Table 113. Europe Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 114. Europe Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 115. Germany Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 116. Germany Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 117. France Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 118. France Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 119. Italy Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 120. Italy Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 121. United Kingdom Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 122. United Kingdom Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 123. Netherlands Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 124. Netherlands Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 125. Rest of Europe Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 126. Rest of Europe Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 127. MEA Implant Intraocular Lens, by Country USD Million (2025-2030)
  • Table 128. MEA Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 129. MEA Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 130. Middle East Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 131. Middle East Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 132. Africa Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 133. Africa Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 134. North America Implant Intraocular Lens, by Country USD Million (2025-2030)
  • Table 135. North America Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 136. North America Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 137. United States Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 138. United States Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 139. Canada Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 140. Canada Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 141. Mexico Implant Intraocular Lens, by Type USD Million (2025-2030)
  • Table 142. Mexico Implant Intraocular Lens, by End-users USD Million (2025-2030)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Implant Intraocular Lens: by Type USD Million (2018-2023)
  • Figure 5. Global Implant Intraocular Lens: by End-users USD Million (2018-2023)
  • Figure 6. South America Implant Intraocular Lens Share (%), by Country
  • Figure 7. Asia Pacific Implant Intraocular Lens Share (%), by Country
  • Figure 8. Europe Implant Intraocular Lens Share (%), by Country
  • Figure 9. MEA Implant Intraocular Lens Share (%), by Country
  • Figure 10. North America Implant Intraocular Lens Share (%), by Country
  • Figure 11. Global Implant Intraocular Lens share by Players 2023 (%)
  • Figure 12. Global Implant Intraocular Lens share by Players (Top 3) 2023(%)
  • Figure 13. Global Implant Intraocular Lens share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Alcon, Inc. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 16. Alcon, Inc. (Switzerland) Revenue: by Geography 2023
  • Figure 17. Johnson and Johnson Vision Care, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Johnson and Johnson Vision Care, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Bausch & Lomb Incorporated (Canada) Revenue, Net Income and Gross profit
  • Figure 20. Bausch & Lomb Incorporated (Canada) Revenue: by Geography 2023
  • Figure 21. Carl Zeiss Meditec AG (ZEISS International) (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Carl Zeiss Meditec AG (ZEISS International) (Germany) Revenue: by Geography 2023
  • Figure 23. Rayner (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Rayner (United Kingdom) Revenue: by Geography 2023
  • Figure 25. EyeKon Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. EyeKon Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Lenstec, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Lenstec, Inc. (United States) Revenue: by Geography 2023
  • Figure 29. HumanOptics AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. HumanOptics AG (Germany) Revenue: by Geography 2023
  • Figure 31. Global Implant Intraocular Lens: by Type USD Million (2025-2030)
  • Figure 32. Global Implant Intraocular Lens: by End-users USD Million (2025-2030)
  • Figure 33. South America Implant Intraocular Lens Share (%), by Country
  • Figure 34. Asia Pacific Implant Intraocular Lens Share (%), by Country
  • Figure 35. Europe Implant Intraocular Lens Share (%), by Country
  • Figure 36. MEA Implant Intraocular Lens Share (%), by Country
  • Figure 37. North America Implant Intraocular Lens Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Alcon, Inc. (Switzerland)
  • Johnson and Johnson Vision Care, Inc. (United States)
  • Bausch & Lomb Incorporated (Canada)
  • Carl Zeiss Meditec AG (ZEISS International) (Germany)
  • Rayner (United Kingdom)
  • EyeKon Medical, Inc. (United States)
  • Lenstec, Inc. (United States)
  • HumanOptics AG (Germany)
Additional players considered in the study are as follows:
STAAR Surgical Company (United States) , HOYA CORPORATION (Japan)
Select User Access Type

Key Highlights of Report


Mar 2024 227 Pages 52 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Side Effects occur Lose Vision
  • Increased Intraocular Pressure

Know More About Global Implant Intraocular Lens Market Report?